Cutera, Inc. (NASDAQ:CUTR)
Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide.
Known medically as onychomycosis, nail fungus often causes the toenails to become discolored, thickened and separated from the nail bed. Approximately half of the population will have at least one infected toenail during the course of their lives. Current treatment options include prescription topicals and oral drugs, both with limited success rates. Some patients are not candidates for oral medications, due to concerns of liver damage and other treatment limitations. ( Read More http://crwepicks.com/?p=15094 )
For more information about this company please visit http://www.cutera.com
National Health Partners, Inc. (OTC:NHPR)
Living without health insurance is a risk no one should have to take. Each year, the cost of health insurance skyrockets. The uninsured rate is higher among people with lower incomes.
National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.”
CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company’s primary target customer group is the 47 million Americans who have no health insurance of any kind. The company’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage. ( Read More http://crwepicks.com/?p=15094 )
For more information about this company please visit http://www.nationalhealthpartners.com
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
PWRM uses its Proteomic-based platform to analyze breast cancer at the protein level. To date, they have identified over 120 distinct biomarkers relating to breast cancer. In collaboration with a major research institute in Houston Texas, the Company has developed the Early Detection Breast Cancer Test, BC-SeraPro™. This test indicates, years prior to mammography, whether the patient has an early indication for breast cancer and if they require more testing or treatment. ( Read More http://crwepicks.com/?p=15094 )
For more information about this company please visit http://www.power3medical.com